Kiniksa Pharmaceuticals International Plc (KNSA)
58.60
+1.67
(+2.93%)
USD |
NASDAQ |
May 08, 16:00
58.54
-0.06
(-0.10%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Assets (Quarterly) : 825.28M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 724.00M |
| Amgen, Inc. | 92.50B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 8.591B |
| United Therapeutics Corp. | 6.714B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 219.59M |
| Shareholders Equity (Quarterly) | 605.69M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 3.794 |
| Net Debt Paydown Yield | 0.00% |